Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving blood clotting factor
Reexamination Certificate
2007-02-06
2007-02-06
Saucier, Sandra (Department: 1651)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving blood clotting factor
Reexamination Certificate
active
09890654
ABSTRACT:
The invention relates to a method for determining the concentration of thrombin inhibitors in a non-turbid body liquid or a non-turbid extract from a body liquid. It comprises the following steps. The body liquid is taken from a living body, and the body liquid is subjected to a separation from the turbid matter, if necessary. To the non-turbid body liquid thus obtained are added a coagulation-inhibiting substance not interfering in the transformation prothrombin/active meizothrombin or Mtdesfgl, resp., a chromogenic or fluorogenic substrate not dissociable by active meizothrombin or Mtdesfgl, resp., and a substance dissociating prothrombin into meizothrombin or Mtdesfgl, resp., and as an optional prothrobmin. The thus obtained solution or mixture, resp., is subjected to a wavelength-selective light absorption or light emission measurement as a function of the time. From the reduction of the light absorption or light emission per time unit is determined the amount of the thrombin inhibitor included in the body liquid by comparison to previously determined standard curves.
REFERENCES:
patent: 5529905 (1996-06-01), Lang et al.
patent: 5547850 (1996-08-01), Nowak et al.
patent: 5702912 (1997-12-01), Hemker et al.
patent: 2661080 (1990-02-01), None
patent: 42 03 980 (1993-08-01), None
patent: 199 04 674 (2000-08-01), None
patent: 0 570 355 (1993-11-01), None
patent: 0570355 (1993-11-01), None
Houbouyan et al., “Inhibition of thrombin generation by heparin and LMW heparins: a comparison of chromogenic and clotting methods”, Blood Coagulation and Fibrinolysis 7 : 24-30 (1996).
Han Jin-Hua et al: “Inhibition of meizothrombin and meizothrombin(desF1) by heparin cofactor II.” Journal of Biological Chemistry, vol. 272, No. 45, Nov. 7 1997, pp. 28660-28665.
Doyle M.F. et al.: “Multiple active forms of Thrombin IV. Relative Activities of Meizothrombins” Journal of Biological Chemistry, vol. 265, No. 18, 1990, pp. 10693-10701.
Abstract: 87 :196026 Amidolytic assay of promthrombin activated with ecarin, a procoagulant from Exhis carinatus venom, 7-Enzymes, vol. 87, 1977; 196035.
“Role of Meizothrombin and Meizothrombin-(des F1) in the Conversion of Prothrombin to Thrombin by theEchis carinatusVenom Coagulant”, Moo-Jhong Rhee et al., Biochemistry 1982, 21, 3437-3443.
Bucha Elke
Nowak Gotz
Haemosys GmbH
Millen White Zelano & Branigan
Saucier Sandra
LandOfFree
Method for determining the concentration of thrombin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for determining the concentration of thrombin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for determining the concentration of thrombin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3866449